Biolinerx Stock Market Value
| BLRX Stock | USD 0.32 0.23 41.82% |
| Symbol | BioLineRx |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLineRx. If investors know BioLineRx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLineRx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of BioLineRx is measured differently than its book value, which is the value of BioLineRx that is recorded on the company's balance sheet. Investors also form their own opinion of BioLineRx's value that differs from its market value or its book value, called intrinsic value, which is BioLineRx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLineRx's market value can be influenced by many factors that don't directly affect BioLineRx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLineRx's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLineRx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLineRx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioLineRx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLineRx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLineRx.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in BioLineRx on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding BioLineRx or generate 0.0% return on investment in BioLineRx over 30 days. BioLineRx is related to or competes with Ardelyx, Lexicon Pharmaceuticals, Seres Therapeutics, Immunitybio, X4 Pharmaceuticals, Mereo BioPharma, and Inozyme Pharma. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology More
BioLineRx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLineRx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLineRx upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 59.21 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 4.88 |
BioLineRx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLineRx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLineRx's standard deviation. In reality, there are many statistical measures that can use BioLineRx historical prices to predict the future BioLineRx's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.01) | |||
| Total Risk Alpha | (1.87) | |||
| Treynor Ratio | (4.12) |
BioLineRx Backtested Returns
BioLineRx secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. BioLineRx exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLineRx's Risk Adjusted Performance of (0.10), mean deviation of 3.81, and Standard Deviation of 6.77 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.24, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioLineRx's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioLineRx is expected to be smaller as well. At this point, BioLineRx has a negative expected return of -0.98%. Please make sure to confirm BioLineRx's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if BioLineRx performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.39 |
Poor reverse predictability
BioLineRx has poor reverse predictability. Overlapping area represents the amount of predictability between BioLineRx time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLineRx price movement. The serial correlation of -0.39 indicates that just about 39.0% of current BioLineRx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
BioLineRx lagged returns against current returns
Autocorrelation, which is BioLineRx stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioLineRx's stock expected returns. We can calculate the autocorrelation of BioLineRx returns to help us make a trade decision. For example, suppose you find that BioLineRx has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioLineRx regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioLineRx stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioLineRx stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioLineRx stock over time.
Current vs Lagged Prices |
| Timeline |
BioLineRx Lagged Returns
When evaluating BioLineRx's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioLineRx stock have on its future price. BioLineRx autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioLineRx autocorrelation shows the relationship between BioLineRx stock current value and its past values and can show if there is a momentum factor associated with investing in BioLineRx.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.